CA2178021C - Produit de remplacement du tabac - Google Patents
Produit de remplacement du tabacInfo
- Publication number
- CA2178021C CA2178021C CA 2178021 CA2178021A CA2178021C CA 2178021 C CA2178021 C CA 2178021C CA 2178021 CA2178021 CA 2178021 CA 2178021 A CA2178021 A CA 2178021A CA 2178021 C CA2178021 C CA 2178021C
- Authority
- CA
- Canada
- Prior art keywords
- nicotine
- dosage form
- patient
- mouth
- matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/636,828 US5824334A (en) | 1989-09-05 | 1996-04-19 | Tobacco substitute |
US08/636,828 | 1996-04-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2178021A1 CA2178021A1 (fr) | 1997-10-20 |
CA2178021C true CA2178021C (fr) | 1999-09-28 |
Family
ID=24553502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2178021 Expired - Lifetime CA2178021C (fr) | 1996-04-19 | 1996-06-03 | Produit de remplacement du tabac |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2784347B2 (fr) |
AU (1) | AU681323B1 (fr) |
CA (1) | CA2178021C (fr) |
NO (1) | NO319057B1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
SE0202365D0 (sv) * | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
EP1578422B1 (fr) * | 2002-12-20 | 2007-04-11 | NicoNovum AB | Materiau particulaire contenant de la nicotine et de la cellulose microcrystalline chimiquement et physiquement stable |
SI1617823T1 (sl) * | 2003-01-24 | 2019-07-31 | Nicachet Ab | Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje |
SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
CA2761737A1 (fr) | 2009-05-11 | 2010-11-18 | U.S. Smokeless Tobacco Company Llc | Procede et dispositif pour aromatiser du tabac sans fumee |
FR2987561B1 (fr) * | 2012-03-02 | 2014-04-11 | Pf Medicament | Dispositif transdermique comprenant des micro-particules poreuses |
CN104411297B (zh) * | 2012-03-27 | 2017-10-24 | 尼科辛诺公司 | 尼古丁制剂 |
US10532046B2 (en) * | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2230439A (en) * | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
US5048544A (en) * | 1990-08-10 | 1991-09-17 | Robert Mascarelli | Cigarette substitute |
GB9111224D0 (en) * | 1991-05-24 | 1991-07-17 | Charwell Consumer Prod | Smoking substitute preparation |
-
1996
- 1996-06-03 CA CA 2178021 patent/CA2178021C/fr not_active Expired - Lifetime
- 1996-06-04 AU AU54700/96A patent/AU681323B1/en not_active Expired
- 1996-07-03 NO NO19962808A patent/NO319057B1/no not_active IP Right Cessation
- 1996-08-01 JP JP8203557A patent/JP2784347B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU681323B1 (en) | 1997-08-21 |
NO962808L (no) | 1997-10-20 |
JPH09286729A (ja) | 1997-11-04 |
JP2784347B2 (ja) | 1998-08-06 |
NO319057B1 (no) | 2005-06-13 |
NO962808D0 (no) | 1996-07-03 |
CA2178021A1 (fr) | 1997-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5824334A (en) | Tobacco substitute | |
US5783207A (en) | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine | |
JP5845194B2 (ja) | ニコチン含有ソフトゼラチントローチ | |
JP2749198B2 (ja) | 経粘膜性剤形 | |
US5855908A (en) | Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient | |
AU668004B2 (en) | Compositions and methods of manufacture of oral dissolvable medicaments | |
US20020160043A1 (en) | Compositions and method of manufacture for oral dissolvable dosage forms | |
US6893654B2 (en) | Two-stage transmucosal medicine delivery system for symptom relief | |
JP2602043B2 (ja) | ニコチン含有流動媒質を含む口経投与用カプセル | |
US8846075B2 (en) | Composition material for transmucosal delivery | |
US6583160B2 (en) | Nicotine therapy method and oral carrier for assuaging tobacco-addiction | |
US6685951B2 (en) | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine | |
JP2012505878A (ja) | 複数部分口内剤形及びその使用 | |
AU2004206199A1 (en) | A composition material for transmucosal delivery | |
US20030022910A1 (en) | Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine | |
CA2178021C (fr) | Produit de remplacement du tabac | |
WO2003004002A1 (fr) | Administration sublinguale de dihydroergotamine pour traiter la migraine | |
EP0745380B1 (fr) | Substitut de tabac | |
US20070190117A1 (en) | Buccal formulations of galanthamine and uses thereof | |
US20030198669A1 (en) | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20160603 |